Workflow
Vantage Corp Announces Full Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
Globenewswire· 2025-06-19 04:05
文章核心观点 - 船务经纪公司Vantage Corp首次公开募股的承销商全额行使超额配售权,公司总发行股份和总收益增加 [1][2] 公司基本信息 - 公司由五名经验丰富的船务经纪人于2012年创立,在油轮市场提供全面船务经纪服务,包括运营支持和咨询服务,业务覆盖清洁石油产品、石化产品、脏石油产品、生物燃料和植物油等,还设有销售与项目团队、研究/战略团队和IT团队,是石油公司、贸易商、船东和商业经理之间的重要中介,目前在新加坡和迪拜运营 [7] 首次公开募股情况 - 承销商全额行使超额配售权,额外购买487,500股A类普通股,每股发行价4美元,新增总收益195万美元 [1] - 行使超额配售权后,公司此次发行的A类普通股总数增至3,737,500股,总收益增至1495万美元,期权交割日期为2025年6月18日 [2] - 公司A类普通股于2025年6月12日在NYSE American开始交易,股票代码为“VNTG” [2] 承销与法律相关 - Network 1 Financial Securities, Inc.担任此次发行的独家主承销商和簿记管理人,Loeb & Loeb LLP担任公司法律顾问,Hunter Taubman Fischer & Li LLC担任Network 1 Financial Securities, Inc.的法律顾问 [3] - 此次发行依据公司的F - 1表格注册声明进行,该声明最初于2024年10月9日提交给美国证券交易委员会(SEC),并于2025年6月11日生效,发行仅通过招股说明书进行,最终招股说明书于2025年6月13日提交给SEC [4] 投资者关系 - 投资者关系联系人是John Yi和Steven Shinmachi,所属公司为Gateway Group, Inc.,联系电话949 - 574 - 3860,邮箱VNTG@gateway - grp.com [8]
Trupanion Announces Winners of the Veterinary Appreciation Day™ Awards
Globenewswire· 2025-06-19 04:05
Trupanion reveals 12 winners, following thousands of nominations from veterinary professionals, pet parents, and pet loversSEATTLE, June 18, 2025 (GLOBE NEWSWIRE) -- In honor of Veterinary Appreciation Day on June 18, Trupanion, the leading provider of medical insurance for cats and dogs in North America, held its annual awards event to celebrate and recognize the veterinary community for their profound impact on the lives of pets and their families. This year, the awards program saw an incredible outpourin ...
Century Communities Sets Date for Second Quarter 2025 Earnings Release and Conference Call
Prnewswire· 2025-06-19 04:05
GREENWOOD VILLAGE, Colo., June 18, 2025 /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS), a leading national homebuilder, today announced that the Company will release its second quarter 2025 financial results after the market closes on Wednesday, July 23, 2025. A conference call will be held that same day at 5:00 p.m. Eastern time, 3:00 p.m. Mountain time, to review the Company's second quarter results, discuss recent events and conduct a question-and-answer session.Webcast:The conference call will be ...
Itron Announces Participation at Upcoming Investor Conference
Globenewswire· 2025-06-19 04:05
LIBERTY LAKE, Wash., June 18, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today that it will participate in the J.P. Morgan 2025 Energy, Power, Renewables & Mining Conference on Wed., June 25, 2025, in New York City. Tom Deitrich, Itron’s president and CEO, will participate in a fireside chat and investor meetings. About Itron Itron is transforming how the world manages energy, water and city services. Our t ...
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
Globenewswire· 2025-06-19 04:05
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholdersSAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at www.v ...
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
GlobeNewswire News Room· 2025-06-19 04:01
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated promising efficacy with durable CAR-T cell persistence and a favorable safety profile, including a 97% complete response rate, 100% MRD negativity in evaluable patients, sustained CAR-T expansion up to 21 months, and low rates of severe CRS and ICANS, with no deaths reported Mechelen, Belgium; J ...
CMS Energy Announces the Pricing Terms of its Cash Tender Offer for Certain Outstanding Debt Securities
Prnewswire· 2025-06-19 04:01
JACKSON, Mich., June 18, 2025 /PRNewswire/ -- CMS Energy Corporation ("CMS Energy") (NYSE: CMS) announced today the pricing terms of the outstanding bonds listed in the table below (the "Bonds") pursuant to the previously announced cash tender offer (the "Tender Offer") for up to $147.095 million aggregate principal amount (the "Aggregate Tender Cap") of the Bonds and certain other series of bonds specified in the Offer to Purchase, dated June 4, 2025 (the "Offer to Purchase") relating to the Tender Offer, ...
Ocugen: Three Potential Gene-Therapy Filings By 2028
Seeking Alpha· 2025-06-19 04:00
Ocugen Inc. (NASDAQ: OCGN ) is a clinical-stage biotechnology company developing an interesting pipeline of modifier gene therapies for rare inherited retinal diseases. In particular, their focus is on those diseases that cause progressive vision lossMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate degree in Busi ...
Lyft CMO Brian Irving talks 'customer-obsessed' marketing and product development
Business Insider· 2025-06-19 04:00
Share icon An curved arrow pointing right. LinkedIn Copy Link Description Angle down icon An icon in the shape of an angle pointing down. ...
Which Nuclear Energy Stock, Oklo or NuScale, Offers Better Gains?
ZACKS· 2025-06-19 04:00
Key Takeaways OKLO surged after winning a DoD deal to supply off-grid nuclear power at a remote Alaska Air Force base. SMR gained traction as the only NRC-approved SMR tech, backed by ENTRA1 Energy's plant rollout plans. Both stocks benefit from Trump-era nuclear support and trade above key moving averages in bullish patterns.Shares of Oklo Inc. (OKLO) and NuScale Power Corporation (SMR) skyrocketed 195.7% and 118.9% this year due to political support for nuclear energy. What factors are driving this mome ...